<code id='D1CE9B5DAA'></code><style id='D1CE9B5DAA'></style>
    • <acronym id='D1CE9B5DAA'></acronym>
      <center id='D1CE9B5DAA'><center id='D1CE9B5DAA'><tfoot id='D1CE9B5DAA'></tfoot></center><abbr id='D1CE9B5DAA'><dir id='D1CE9B5DAA'><tfoot id='D1CE9B5DAA'></tfoot><noframes id='D1CE9B5DAA'>

    • <optgroup id='D1CE9B5DAA'><strike id='D1CE9B5DAA'><sup id='D1CE9B5DAA'></sup></strike><code id='D1CE9B5DAA'></code></optgroup>
        1. <b id='D1CE9B5DAA'><label id='D1CE9B5DAA'><select id='D1CE9B5DAA'><dt id='D1CE9B5DAA'><span id='D1CE9B5DAA'></span></dt></select></label></b><u id='D1CE9B5DAA'></u>
          <i id='D1CE9B5DAA'><strike id='D1CE9B5DAA'><tt id='D1CE9B5DAA'><pre id='D1CE9B5DAA'></pre></tt></strike></i>

          Home / comprehensive / hotspot

          hotspot


          hotspot

          author:hotspot    Page View:715
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In